No abstract available
Keywords:
androgen deprivation therapy; androgen‐receptor axis–targeted therapies; cognitive decline; cognitive impairment; hormonal therapy; prostate cancer; subjective cognitive decline.
MeSH terms
-
Androgen Antagonists / adverse effects
-
Androgen Antagonists / therapeutic use
-
Antineoplastic Agents, Hormonal* / adverse effects
-
Antineoplastic Agents, Hormonal* / therapeutic use
-
Cognition* / drug effects
-
Humans
-
Male
-
Prostatic Neoplasms* / drug therapy
Substances
-
Antineoplastic Agents, Hormonal
-
Androgen Antagonists